This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
申请公布号
KR20120110091(A)
申请公布日期
2012.10.09
申请号
KR20127009259
申请日期
2009.09.15
申请人
TAIGEN BIOTECHNOLOGY CO., LTD.
发明人
LIU CHEN FU;LEE KUANG YUAN;CHENG PEI CHIN;LIU YO CHIN;LO PIN;TSENG KUO FENG;CHEN CHIH MING;KING CHI HSIN RICHARD;LIN CHU CHUNG
